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Introduction: Spontaneous regression of cancer is thought to be a rare event. Here, we report an extremely rare
case of repeated episodes of spontaneous regression and progression of recurrent cervical adenocarcinoma.
Case presentation: We report here a case of a 56-year-old Japanese woman who was diagnosed with cervical
adenocarcinoma. Her hilar and mediastinal lymph nodes were swollen 6 years after the initial diagnosis and subsequent
treatment, and were found to be pathologically malignant by mediastinal biopsy. Then, without any treatment, the hilar
and mediastinal lymph nodes spontaneously regressed with decreases in tumor size and serum tumor marker
levels, as confirmed by a decrease in uptake of fluorodeoxyglucose during positron emission tomography-computed
tomography. Subsequently, although there were repeated episodes of increase and decrease in her serum tumor marker
levels and lymph node size, her activities of daily living were and are well preserved.
Conclusions: While spontaneous regression of a malignant tumor is a rare event, our case is even rarer in that repeated
episodes of spontaneous regression/progression of cervical adenocarcinoma occurred.
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The widely adopted definition of spontaneous regression
of cancer is “the partial or complete disappearance of a
malignant tumor in the absence of treatment or in the
presence of therapy considered inadequate to exert a sig-
nificant influence on the disease” as proposed by Everson
and Cole in 1966 [1]. Spontaneous regression of cancer is
thought to be a rare event with an incidence of one in
60,000 to 100,000 [2], and more than half of these events
occur in malignant melanoma, renal cell carcinoma,
hematopoietic cancer, and neuroblastoma [3]. Here, we
report an extremely rare case of repeated episodes of
spontaneous regression and progression of recurrent
cervical adenocarcinoma.Case presentation
A 56-year-old Japanese woman was referred to the
gynecology department at our hospital with complaints* Correspondence: atsuto-katano@umin.ac.jp
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unless otherwise stated.of vaginal bleeding in August 1997. She was found to
have a cervical mass, which was biopsied and diagnosed
as an adenocarcinoma (Figure 1). A pelvic examination
revealed a 1 to 2cm cervical mass invading her vagina
on the posterior lip of her cervix. On rectovaginal exam-
ination, the parametria and posterior fornix seemed to
be free of disease. Her serum tumor markers were ele-
vated: carcinoembryonic antigen (CEA) was 10.5ng/mL
(<5ng/mL), carbohydrate antigen 19–9 (CA19-9) was
151U/mL (<37U/mL), and carbohydrate antigen 125
(CA-125) was 343U/mL (<30U/mL). T2-weighted pelvic
magnetic resonance imaging showed a cervical lesion of
1×1.5cm without parametrial invasion, lymphadenopathy
or metastasis, compatible with the International Federation
of Gynecology and Obstetrics stage IIa. Total abdominal
hysterectomy with bilateral salpingo-oophorectomy and
pelvic lymphadenectomy were performed in September
1997. The final pathology demonstrated a 1.5×1.5×1.0cm
highly differentiated papillary adenocarcinoma with
myometrial invasion confined to less than one-half of herThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Histopathological analysis of the biopsy sample taken
during the patient’s first visit. It revealed an adenocarcinoma involving
the uterine cervix. Small cells are arranged in a dense papillary or tubular
growth pattern. A portion of tumor cells remain regular glands.
Hematoxylin and eosin stain, low power.
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vasion. The surgical margins were free of cancer. A total
of 36 lymph nodes were dissected; one of the lymph
nodes, located in the left iliac lymph node, was positive for
disease, compatible with pathological stage T2aN1M0.
Based on pathologic risk factors, we recommended her for
adjuvant chemoradiation therapy. She was administered
two 21-day courses of chemotherapy comprising a com-
bination of cisplatin (110mg/body) on day 1, mitomycin C
(11mg/body) on day 1, and etoposide (150mg/body) on
days 1, 3, and 5, followed by pelvic radiation therapy; the
clinical target volume included the uterus, cervix, vagina,Figure 2 Hilar lymph node metastases appeared 6 years after initial treatmen
image of the patient’s chest performed in July 2003. The arrow indicates
are elevated as follows: carcinoembryonic antigen was 43.8ng/mL, carbo
was 343U/mL in June 2003. B) The lymph node (arrow) decreased to 65%
tumor markers were decreased as follows: carcinoembryonic antigen was 27.1
antigen 125 was 188U/mL.as well as the presacral, obturator, and external, internal,
and common iliac lymph nodal groups: 10MV X-ray par-
allel opposed pair two-field box and 50Gy in 2Gy daily
fractions were used.
The serum tumor marker levels decreased significantly
after the initial treatment, and she showed no signs
of recurrence. From June 1998, she needed short
hospitalization repeatedly because she had symptoms
of ileus possibly induced by surgical operation or
radiotherapy, and transverse colectomy was performed at
our hospital in August 1999. She had an uneventful post-
operative course and has not been hospitalized for further
abdominal problems since then.
Her serum tumor markers gradually elevated from
May 2002: CA-125 was 93U/mL, CEA was 11.7ng/mL,
and CA19-9 was 15U/mL in May 2002; CEA was
21.3ng/mL, CA19-9 was 23U/mL, and CA-125 was
114U/mL in November 2002; and CA-125 was 344U/mL,
CEA was 47.5ng/mL, and CA19-9 was 139U/mL in April
2003. In May 2003, a computed tomography (CT) scan
revealed bilateral hilar and mediastinal lymphadenopathy
(Figure 2A). Biopsy of the mediastinal lymph nodes was
done in July 2003. She was diagnosed with adenocar-
cinoma, consistent with recurrence (Figure 3). We rec-
ommended salvage chemotherapy to our patient, but
she was not compliant with the recommendations and
the treatment was never delivered. Without treatment,
the serum tumor marker levels gradually decreased:
CEA was 52.8ng/mL, CA19-9 was 124U/mL, and CA-125
was 231U/mL in January 2004; and CEA was 32.4ng/mL,
CA19-9 was 33U/mL, and CA-125 was 180U/mL in
January 2005. A CT scan also demonstrated a reductiont of the primary tumor. A) A contrast-enhanced computed tomography
a contrast-enhancing enlarged lymph node. Serum tumor markers
hydrate antigen 19–9 was 151U/mL, and carbohydrate antigen 125
of its peak volume in June 2005, 2 years after the recurrence. Serum
ng/mL, carbohydrate antigen 19–9 was 27U/mL, and carbohydrate
Figure 3 Histopathological analysis of the mediastinal
lymphadenopathy in July 2003. The sample thought to be a
recurrent lesion revealed a moderately to poorly differentiated
adenocarcinoma. The tumor cells with round nuclei, eosinophilic
cytoplasm, and distinct cell borders are arranged in sheets and show
alveolar or solid growth pattern with some glandular cavity. A large
number of tumor cells have mucinous cytoplasm. The histologic
examination of the primary lesion, which is diagnosed as a “well-
differentiated” adenocarcinoma, is inconsistent with the recurrent
lesion. However, inconsistent histological analysis between metastatic
and primary tumors often occurs. The primary lesion also contains a
sheet-like structure, so there is some consistency in diagnosis of this
lesion as a recurrence. Hematoxylin and eosin stain, low power.
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hilar lymph nodes) in June 2005 (Figure 2B).
In October 2006, her serum tumor markers were
again highly elevated: CA-125 was 134U/mL, CEA was
39.3ng/mL, and CA19-9 was 138U/mL. Further, posi-
tron emission tomography-CT (PET-CT) imaging re-
vealed a new lesion located in her right supraclavicular
lymph node (maximum standardized uptake value,
SUV max, 6.0) in addition to the existing lesions in her
mediastinal (SUV max 6.0) and bilateral hilar (SUV
max 14.9) lymph nodes. Although she remained un-
treated, PET-CT imaging in October 2008 revealed that
her right supraclavicular lymph node had no significant
uptake and the other lesions had decreased uptake
of fluorodeoxyglucose (18F-FDG; mediastinal lymph
node, SUV max 9.2; right hilar lymph node, SUV max
5.0; left hilar lymph node, SUV max 3.0). A new swollen
lymph node with a size of 8.6cm3 on CT scan appeared in
her right axillary lymph node in September 2012, but it
was reduced to 3.4cm3 in February 2014. A 15mm-
diameter nodule, which was observed in the S2 segment
of her right upper lobe on CT scan in February 2014 and
formed a cavity, reduced in volume by July 2014. She is
currently in good condition without any cancer treatment
from the time of recurrence and has survived for about
18 years after the initial diagnosis. Her performancestatus is still excellent (Karnofsky performance status
score, 100%).
A follow-up examination included a physical examin-
ation, assessment of tumor markers, and CT scan. Figure 4
shows the changes in serum tumor markers (CA19-9,
CA-125, and CEA) and volume of the axillary and
mediastinal lymph nodes.
Discussion
Our case met Everson and Cole’s definition since she
experienced partial regression of the lesion that was
diagnosed as malignant without any medical treat-
ment. There are several presumed mechanisms of
spontaneous regression: (1) immunological mechanism,
(2) hormone-induced stimulation, (3) impact of infectious
diseases, (4) traumatic effect of surgical operation, (5)
nutritional/circulatory deficiency of tumor, (6) abrasion
of superficial tumors, (7) elimination of carcinogen or
tumor growth factor, (8) psychotherapy or alteration of
mental state, and (9) complementary and alternative
medicine [4-6]. Immunological mechanism is thought
to be the most important factor, and the study of anti-
tumor immune responses has received enhanced interest
in recent years.
Programmed cell death 1 (PD-1), which is expressed
on the surface of T lymphocytes, and its ligand (pro-
grammed death-ligand 1; PD-L1) negatively regulate
the immune response [7]. Many tumor cells express
PD-L1 and protect themselves from the body’s immune
system. Immunotherapy via inhibition of the inter-
action between PD-1 and PD-L1 by anti-PD-1 antibody
is effective in advanced melanoma and kidney cancer [8].
We suspect that the spontaneous regression process in
our case was a result of the ongoing competition between
the immune system and tumor progression; when the
anti-tumor response of the immune system became pre-
dominant, the cancer regressed, and when the immune
system was weakened, the cancer progressed. This balance
of the opposing forces probably led to the repeated epi-
sodes of regression and progression rather than complete
remission. The exact situation in our patient and the
mechanisms that govern these opposing forces are unclear,
but the PD-1/PD-L1 anti-tumor immune system may be
involved. We are considering performing immunostaining
for PD-L1 on future biopsy samples from the patient to
shed more light on this mechanism.
In our case as there were a limited number of relapsed
sites, called oligometastases or oligo-recurrence [9], the
immunological response may have been caused by an
abscopal effect, a phenomenon in which local radiotherapy
is associated with the regression of a metastatic lesion that
is located at a distance from the irradiated site. A recent
report showed that irradiation of the mediastinum re-
sulted in regression of an untreated lung tumor [10]. In a
Figure 4 Changes in serum tumor markers and volume of the axillary and mediastinal lymph nodes. The changes in serum tumor markers
(carbohydrate antigen 19–9, carbohydrate antigen 125, and carcinoembryonic antigen) and volume of the axillary and mediastinal lymph nodes
from initial presentation until present. The black solid line indicates the serum level of carcinoembryonic antigen, the gray solid line indicates the
serum level of carbohydrate antigen 19–9, and the gray dotted line indicates the serum level of carbohydrate antigen 125. Abbreviations: CA,
carbohydrate antigen; CEA, carcinoembryonic antigen.
Katano et al. Journal of Medical Case Reports  (2015) 9:114 Page 4 of 5patient with advanced uterine cervical carcinoma,
para-aortic lymph node metastasis showed an abscopal
effect of radiation therapy [11]. While radiotherapy
has been predominantly focused on direct damage to
malignant cells, there is increasing evidence that it can
also lead to significant alterations in the tumor micro-
environment, particularly with respect to effects on
immune cells and infiltrating tumors [12]. A recent
study indicates that the abscopal effect might have the
potential to affect disappearance of micrometastases
[13]. It is not typical that the abscopal effect is so
long-lasting considering the long interval between the
time of irradiation (1997) and spontaneous regression
(2004). However, it is highly possible that the abscopal
effect activated an anti-tumor response of the immune
system in our patient that resulted in the repeated
episodes of tumor regression and progression.
Conclusions
Spontaneous regression has intrigued clinicians for many
years; however, little is known about why it occurs. Our
patient demonstrated an intriguing clinical course of
repeated episodes of spontaneous regression/progression
of pathologically confirmed malignant lesions. Despite the
unknown underlying causes of spontaneous regression,
the potential contribution of such knowledge is thought to
be essential to treatment or prevention of cancer.Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying im-
ages. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.
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